Startup Funding Instruments: CCPS, SAFE and the Term Sheet, Exam-Ready Notes

CommerceCommerce9 min readUpdated Aug 23, 2026

A startup does not raise money the way a shop does. There is no collateral, no order book to lend against, usually no profit to discount. What a startup sells instead is a slice of its own future — and over the last decade India’s founders and investors have converged on a small set of instruments engineered for exactly that sale. This card explains the two most important of them: CCPS and SAFE, along with the funding ladder they live on.

It is a standalone card in the commerce track, but it leans on the series the site already runs: The first card of the financial management series built the frame of investment and financing decisions, and the working capital card covered the short-term end of the firm’s money. This card is the frontier version of the same questions — applied to companies that have no history to finance.

Why Startups Need Special Instruments

The mismatch that ordinary debt and equity cannot handle.

  1. No cash flows. Debt is repaid out of cash flow; a pre-revenue startup has none — so classic lending is unavailable regardless of the idea’s quality.
  2. Valuation impossible. Early-stage price discovery is guesswork; pricing equity directly at seed stage would freeze a bad number into the cap table permanently.
  3. Speed. Rounds must close in weeks, not quarters — instruments requiring valuations, audits and negotiations defeat their own purpose.
  4. Control. Founders cannot sell voting equity at every round and still run the company; investors cannot buy common stock and carry founder-level risk.

The Funding Ladder

The stages any instrument discussion assumes — know the map before the vehicles.

  1. Pre-seed and bootstrapping. Founders, friends and family, angels — small tickets, personal risk, often on simple notes until a company even exists to hold shares.
  2. Seed. First institutional money — angels and seed funds; SAFEs and CCPS both dominate here; the round that buys the first team and first product.
  3. Series A/B/C. Venture capital — priced rounds, due diligence, board seats; CCPS is the workhorse instrument from here onward.
  4. Later rounds and exit. Growth equity, strategic sale or IPO — where the conversion privileges negotiated years earlier finally pay off.
  5. The rule. Each stage prices risk differently — instruments evolve down the ladder because the questions investors can ask (and answer) change at every rung.

CCPS: The Workhorse of Indian Rounds

Compulsorily Convertible Preference Shares — the instrument most Indian VC rounds are actually made of.

  1. The instrument. Preference shares that must convert into equity — holders rank ahead of common stock for dividends and liquidation until conversion, then become ordinary shareholders.
  2. Why investors insist. Downside protection first: liquidation preference returns the investment (sometimes with a multiple) before common shareholders see anything in a sale.
  3. Why founders accept. No repayment pressure like debt, and conversion terms (ratio, trigger events) negotiated once, applying automatically at the qualifying round.
  4. The conversion mechanics. Typically at a discount to the next round’s price, or capped — the thumb-rule every term sheet argues over.
  5. The regulatory note. Indian pricing guidelines and FEMA valuation rules apply to CCPS issued to foreign investors — the compliance layer that SAFEs outside India never face.

SAFE: The Silicon Valley Import

Simple Agreement for Future Equity — the speed instrument.

  1. The instrument. Not a share at all: a right to receive equity in a future priced round, against cash paid today — Y Combinator’s 2013 standardisation made it the default US seed doc.
  2. The two dials. Valuation cap and/or discount — the holder converts at the better of capped price or discounted price of the next round; the dials, not a valuation, are the negotiation.
  3. Why it spreads. Five pages, no valuation fight, no chartered accountant — closings in days; for very early cheques it is the cheapest paper that works.
  4. The Indian caveat. Indian company law and FEMA make speed-paper harder — pure SAFEs fit poorly with the rules that govern share issuance, so Indian variants usually route through CCDs or wait for a CCPS round.
  5. The stack risk. Multiple SAFE layers with different caps convert at the priced round into a cap table no one has fully seen — the due diligence surprise buyers find at Series B.

CCPS vs SAFE: Head to Head

The comparison table every exam and every term sheet wants.

  1. Legal form. CCPS is a share with statutory protection; a SAFE is a contract right — the difference in a bankruptcy is the difference between owner and creditor of nothing.
  2. Timing of equity. CCPS holds equity from day one (convertible later); SAFE holders own nothing until conversion — a distinction worth a full mark on its own.
  3. Valuation. CCPS prices the round; SAFE defers pricing entirely — deferral is the feature and the bug.
  4. Speed and cost. SAFE wins on both; CCPS trades speed for certainty and regulatory comfort.
  5. Jurisdiction. CCPS is routine in India; SAFE is routine in the US — instrument choice follows governing law more than founder preference.
  6. The synthesis. Early and small: SAFE’s speed; institutional and Indian: CCPS’s protection — most real cap tables carry both histories.

ESOPs and the Founder-vesting Carve-out

The other instruments in every modern cap table.

  1. ESOP mechanics. Options granted at a strike price, vesting over years (typically four with a one-year cliff), exercised on leaving or exit — the standard employee incentive pool.
  2. Why pools pre-exist. Investors require an option pool (often 10-15%) to be created before their money arrives — dilution lands on founders, not the incoming round.
  3. Founder vesting. Investors impose vesting on founders too — unvested shares repurchased at par if a founder leaves early; the clause that keeps teams together after the money arrives.
  4. The accounting note. Options are a compensation cost, not a financing line — the expense treatment trips MBA exams and CFOs alike.
  5. The design rule. Pools too small guarantee a mid-round renegotiation; pools too large dilute founders before any hire justifies it — sizing the pool is a forecasting exercise, not a favour.

Term Sheet Arithmetic Founders Must Know

Four numbers that decide who actually owns what.

  1. Liquidation preference. 1x non-participating is the fair default — the investor takes 1x their money back or converts to common, whichever is better; participating stacks returns and belongs in negotiations, not defaults.
  2. Valuation: pre vs post. Post-money = pre-money + investment — the same cheque buys different fractions depending on which word the term sheet uses; the classic founder arithmetic trap.
  3. The option pool shuffle. Pool created in the pre-money effectively transfers a few percent from founders to the round — invisible in the headline number, decisive in the cap table.
  4. Anti-dilution. Broad-based weighted average protects investors in down rounds without wiping founders; full-ratchet does the wiping; the clause names are worth one precise line each.
  5. The board rule. Board composition and protective provisions matter more than headline valuation — control terms decide who the company answers to between rounds.

How the Instruments Behave in Outcomes

Every instrument is a bet on an exit scenario — read them as such.

  1. The good exit. Sale above preferences: CCPS converts, SAFEs convert, everyone shares pro-rata — the cap table works as designed.
  2. The middling exit. Sale near the invested amount: preferences absorb the price — investors made whole, common shares get little; the moment CCPS protection earns its keep.
  3. The down round. New money at a lower price: anti-dilution adjusts old holders upward, founders absorb the dilution — the clause that was boilerplate becomes the whole story.
  4. The shutdown. Preference ranks ahead of common in liquidation — in practice little is left after secured debt; SAFEs stand behind even that, holding conversion rights over a company that never priced a round.
  5. The lesson. Instruments are probability-weighted claims — a founder who reads them as “money in” instead of claims-out is negotiating blindfolded.

How Exams Ask This Card

The question shapes with their marking engines.

  1. Instrument comparisons. CCPS vs SAFE — form, timing of equity, valuation, jurisdiction; six labelled lines score full marks.
  2. Ladder questions. Stages of startup funding with instruments dominant at each — the map plus one sentence per rung.
  3. Numericals. Post-money arithmetic, option pool effect on founder stake, SAFE conversion at cap vs discount — clean fractions, easy marks lost only to mislabelled terms.
  4. Short notes. Liquidation preference, ESOP vesting, anti-dilution — definition, mechanics, one line of critique each.
  5. The trap watch. Pre vs post money, participating vs non-participating, discount vs cap — the pairs that get swapped under exam pressure; label every line.

Quick Revision: Ten Lines

One glance before the hall.

  1. Why special instruments. No cash flow, unpriceable valuation, need for speed, founder control.
  2. Ladder. Bootstrapping → seed → Series A/B/C → exit; instruments change with pricing ability.
  3. CCPS. Preference shares that must convert; liquidation preference is the protection.
  4. SAFE. Contract right to future equity; cap and discount are the only dials; speed is the point.
  5. India vs US. CCPS routine under Indian law and FEMA; SAFE routine in the US.
  6. ESOP. Options vesting over four years with cliff; pool sized pre-round, diluting founders.
  7. Preferences. 1x non-participating is the fair default; participating stacks returns.
  8. Pre vs post. Post = pre + cheque; the same money buys different fractions.
  9. Anti-dilution. Broad-based weighted average fair; full-ratchet punitive in down rounds.
  10. Outcomes. Instruments are claims on exit scenarios — read them as bets, not money.

Conclusion: Paper That Prices the Future

Startup finance is the art of selling a future no one can value yet, and CCPS and SAFE are the two papers that make the sale possible — one trading speed for statutory protection, the other trading certainty for days-not-months closings. This card walked the funding ladder they live on, the arithmetic that quietly moves ownership between founders, employees and investors, and the behaviour of every instrument across the exits that finally reveal what each was worth. For the foundations under this frontier — the investment and financing decisions of an established firm — read the series opener; for the daily discipline of keeping a young firm’s cash loop alive, the working capital card is the companion. The instruments change with every market cycle; the claims logic underneath them does not.

Quick revision

  • No cash flows.: Debt is repaid out of cash flow; a pre-revenue startup has none — so classic lending is unavailable regardless of the idea’s quality.
  • Valuation impossible.: Early-stage price discovery is guesswork; pricing equity directly at seed stage would freeze a bad number into the cap table permanently.
  • Speed.: Rounds must close in weeks, not quarters — instruments requiring valuations, audits and negotiations defeat their own purpose.
  • Control.: Founders cannot sell voting equity at every round and still run the company; investors cannot buy common stock and carry founder-level risk.
  • Pre-seed and bootstrapping.: Founders, friends and family, angels — small tickets, personal risk, often on simple notes until a company even exists to hold shares.
  • Seed.: First institutional money — angels and seed funds; SAFEs and CCPS both dominate here; the round that buys the first team and first product.